Trial Profile
Clinical trial to evaluate the pharmacokinetic behavior of meropenem increased adsorption in membranes (oXiris) in patients with critical septic acute renal dysfunction [ENSAYO CLINICO PARA EVALUAR EL COMPORTAMIENTO FARMACOCINETICO DE MEROPENEM EN MEMBRANAS DE ADSORCION INCREMENTADA (oXiris) EN EL PACIENTE CRITICO SEPTICO CON DISFUNCION RENAL AGUDA]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2012
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections; Sepsis
- Focus Pharmacokinetics
- 19 Mar 2012 New trial record